Summary
This 8-K filing from Edwards Lifesciences Corporation (EW), dated October 21, 2009, announces their financial results for the third quarter of 2009. The report primarily serves to furnish a press release (Exhibit 99.1) containing these results. While the 8-K itself does not detail the specific figures, it directs investors to the accompanying press release for comprehensive information on the company's financial performance during the quarter. This is a standard disclosure to inform stakeholders about recent operational and financial outcomes.
Key Highlights
- 1Edwards Lifesciences Corporation filed an 8-K on October 21, 2009.
- 2The primary purpose of the filing is to report the company's financial results for the third quarter of 2009.
- 3The detailed financial results are provided in an attached press release, designated as Exhibit 99.1.
- 4The filing does not contain specific financial figures within the 8-K text itself, directing readers to the press release.
- 5This report is furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
- 6The filing was signed by Thomas M. Abate, Corporate Vice President, Chief Financial Officer, and Treasurer.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally announce and provide access to Edwards Lifesciences' financial results for the third quarter of 2009 through an attached press release.
The specific financial results for the third quarter of 2009 are detailed in the press release attached as Exhibit 99.1 to this 8-K filing.
No, the 8-K filing text does not contain the specific financial results. It indicates that these results are published in the accompanying press release (Exhibit 99.1).
The report was signed by Thomas M. Abate, who holds the positions of Corporate Vice President, Chief Financial Officer, and Treasurer at Edwards Lifesciences Corporation.